Michelle Haber  (born 18 October 1956) is an Australian cancer researcher.
Haber is an Australian scientist in the field of childhood cancer research. She serves as the Executive Director of Children's Cancer Institute and is a Professor at the School of Women’s and Children’s Health, University of New South Wales. She is known for her discoveries in the area of chemotherapy resistance in neuroblastoma and for translating these discoveries into new therapeutics that are currently in clinical trials.